Kathy Zackowski, PhD, associate vice president of the National Multiple Sclerosis (MS) Society, discusses the importance of MS rehabilitation and lists several successful strategies.
Kathy Zackowski, PhD, associate vice president of the National Multiple Sclerosis (MS) Society, discusses the importance of MS rehabilitation and lists several successful strategies.
MS rehabilitation was further explored at the Americas Committee for Treatment and Research in MS (ACTRIMS) Forum 2024 on March 2 during the session, "Rehabilitation Without Borders."
Transcript
What are the key mechanisms involved in MS rehabilitation?
The goal of rehabilitation is to allow people to do what they want to do. The goal is really to determine what's missing; what are the elements that we need to address to allow people to do that?
We know that there are key biologic mechanisms that drive symptoms and progression. One goal of rehab research is really to identify, what are those particular elements that we can change to allow someone to be more functional? This is complicated because MS has a variety, a large variety, of symptoms, as well as comorbidities that can be controlled. So, weight, smoking, vitamin D, we know all of those things can affect not only the risk of MS, but also progression.
What specific rehabilitation strategies have shown promise in improving the quality of life for patients with MS?
There's a wide variety. The first thing that comes to mind is exercise. There's evidence to suggest that aerobic exercise is good for some people, resistance training is better for some people, and some combination is good for some people.
It's important to recognize that people with different levels of ability can do different types of exercise. So, we need to learn to adapt exercise so that everyone at every level of ability with MS can participate in exercise, and that has been shown to really improve quality of life.
Other things that come to mind are even just walking. There's a study just covering targeted walking, and what they did over 10 weeks is they had people walk on a treadmill. They found that not only were there changes in quality of life, but there were neuroprotective changes, so biologic changes that could be an incentive to people for why exercising is so important.
Fatigue is a really important symptom. As well as improving quality of life, balance exercises have been shown to be really helpful, as well as cognitive behavioral therapy, and even the combination of balance exercises and cognitive behavioral therapy.
Cognitive behavioral therapy addresses these pathways between what your thoughts are, what your feelings are, and what your behaviors are, and really being able to address that through these noninvasive therapies. It has been shown to be really helpful to people's quality of life.
Last but not least, really thinking about mindfulness-based interventions or self-management strategies, things that we can do and think about that decreases our stress, or helps us cope with the stress of our life. Because there's such a variety of interventions, it's really important for MS patients to see an expert, so there are a variety of rehabilitation experts, but those experts really can address which intervention is going to be most effective.
Higher Weight-Adjusted Waist Index Tied to Greater Mortality Risk in Patients With Osteoarthritis
April 23rd 2025Researchers consider the weight-adjusted waist index a more precise predictor of mortality risk in patients with osteoarthritis than traditional obesity measures, like body mass index.
Read More
New Research Challenges Assumptions About Hospital-Physician Integration, Medicare Patient Mix
April 22nd 2025On this episode of Managed Care Cast, Brady Post, PhD, lead author of a study published in the April 2025 issue of The American Journal of Managed Care®, challenges the claim that hospital-employed physicians serve a more complex patient mix.
Listen
What's at Stake as Oral Arguments Are Presented in the Braidwood Case? Q&A With Richard Hughes IV
April 21st 2025Richard Hughes IV, JD, MPH, spoke about the upcoming oral arguments to be presented to the Supreme Court regarding the Braidwood case, which would determine how preventive services are guaranteed insurance coverage.
Read More
Personalized Care Key as Tirzepatide Use Expands Rapidly
April 15th 2025Using commercial insurance claims data and the US launch of tirzepatide as their dividing point, John Ostrominski, MD, Harvard Medical School, and his team studied trends in the use of both glucose-lowering and weight-lowering medications, comparing outcomes between adults with and without type 2 diabetes.
Listen
Key Indicators of Myasthenia Gravis Disease Progression Reduced With Efgartigimod
April 18th 2025Research presented at the recent annual meeting of the Academy of Managed Care Pharmacy highlights outcomes among patients who have anti-acetylcholine receptor antibody-positive myasthenia gravis that include reduced exacerbations and need for immunoglobulin.
Read More